Viewing Study NCT05086861


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2025-12-27 @ 10:12 PM
Study NCT ID: NCT05086861
Status: COMPLETED
Last Update Posted: 2021-10-21
First Post: 2019-08-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation
Sponsor: University Hospital Plymouth NHS Trust
Organization:

Study Overview

Official Title: Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation: A Pilot Study
Status: COMPLETED
Status Verified Date: 2020-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients undergoing hybrid AF ablation second stage catheter ablation have the posterior left atrium mapped to see it if is electrically isolated. This is done via a standard electrophysiogical study in accordance with routine clinical practice.

Investigators propose to check left atrium posterior wall isolation via oesophageal pacing and compare this to findings from invasive study
Detailed Description: Oesophageal temporary pacing of the heart is an established treatment in heart block and several catheters are licenced for this purpose with minimal procedural risks. Due to the position of the oesophagus, pacing from the oesophagus could sense and pace the posterior left atrium. If the posterior wall could be demonstrated to be electrically isolated with oesophageal pacing then invasive electrophysiological study such as the second stage of a hybrid AF ablation would be unnecessary.

This would save patients from undergoing invasive left atrial mapping and exposure to the consequent risks of the procedure.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: